Linkage Biosciences Expands with European Subsidiary | GenomeWeb

NEW YORK (GenomeWeb) – San Francisco-based Linkage Biosciences today announced the launch of a wholly-owned European subsidiary based in Geneva.

The move is in response to global demand for LinkSeq molecular tissue typing technology, the firm said in a statement. The real-time PCR-based human leukocyte antigen testing technology covers 12,000 alleles in a single test, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.